• Testosterone related to neural activity during emotion processing in schizophrenia.
a b s t r a c t
Growing evidence suggests that testosterone may play a role in the pathophysiology of schizophrenia given that testosterone has been linked to cognition and negative symptoms in schizophrenia. Here, we determine the extent to which serum testosterone levels are related to neural activity in affective processing circuitry in men with schizophrenia. Functional magnetic resonance imaging was used to measure blood-oxygen-level-dependent signal changes as 32 healthy controls and 26 people with schizophrenia performed a facial emotion identification task. Whole brain analyses were performed to determine regions of differential activity between groups during processing of angry versus nonthreatening faces. A follow-up ROI analysis using a regression model in a subset of 16 healthy men and 16 men with schizophrenia was used to determine the extent to which serum testosterone levels were related to neural activity. Healthy controls displayed significantly greater activation than people with schizophrenia in the left inferior frontal gyrus (IFG). There was no significant difference in circulating testosterone levels between healthy men and men with schizophrenia. Regression analyses between activation in the IFG and circulating testosterone levels revealed a significant positive correlation in men with schizophrenia (r = .63, p = .01) and no significant relationship in healthy men. This study provides the first evidence that circulating serum testosterone levels are related to IFG activation during emotion face processing in men with schizophrenia but not in healthy men, which suggests that testosterone levels modulate neural processes relevant to facial emotion processing that may interfere with social functioning in men with schizophrenia.
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Introduction
Impaired social functioning is a hallmark of schizophrenia that is gaining increasing attention. Poor social functioning in individuals with schizophrenia has been linked to abnormal processing of facial emotions [1] . A meta-analysis reported a significant positive correlation between severity of negative symptoms and facial emotion perception impairment in schizophrenia [2] . People with schizophrenia also have difficulty identifying and discriminating among different facial expressions [3] , in particular those of negative valence [4, 5] .
The underlying neural network of this impairment is not fully understood although functional neuroimaging studies show abnormalities in the limbic system and frontal cortex when people with schizophrenia are exposed to affective stimuli [5] [6] [7] . Facial affect processing has been frequently studied as a method of exploring the neural substrates of social impairment in schizophrenia. In functional Magnetic Resonance Imaging (fMRI) studies, people with schizophrenia predominantly display hypoactivation in regions normally recruited by healthy individuals during the processing of facial emotions. One study showed that individuals with schizophrenia had diminished limbic response in the left amygdala and bilateral hippocampus during facial emotional discrimination relative to healthy adults [6] . In another study, people with schizophrenia showed significantly less activation than healthy controls in response to angry expressions in the inferior frontal gyrus (IFG), putamen and cerebellum [8] . The first part of the present study was designed to use fMRI to confirm the neural activation patterns underlying the identification of angry compared to non-threatening facial expressions in a sample of men and women with schizophrenia relative to healthy men and women.
Steroid hormones and particularly testosterone have been implicated in emotion processing. Studies have reported both positive and negative associations between testosterone levels and emotion-related neural activation in healthy people. Derntl et al. [9] found a significant positive correlation in healthy men between endogenous testosterone and amygdala response to fearful and angry facial expressions, but no correlation with non-threatening expressions such as sadness and happiness. Similar findings have been reported in healthy women whose endogenous testosterone levels correlated positively with amygdala activity during the processing of fearful and angry faces [10] . Stanton et al. [11] found that endogenous testosterone levels were negatively correlated with amygdala BOLD activity and positively correlated with ventromedial prefrontal cortex BOLD activity during the processing of angry faces; however, both findings occurred only in healthy males. When middle-aged women were given a single dose of testosterone, Van Wingen et al. [10] reported positive correlations between exogenous testosterone and activity in the amygdala and superior frontal cortex along with a negative correlation between exogenous testosterone and neural activity in the orbitofrontal cortex and occipital gyrus in response to angry and fearful facial stimuli. Another study reported a significant increase in neural activity in the amygdala and hypothalamus while viewing angry faces after healthy female participants received a .5 ml dose of testosterone [12] . Altogether, these findings generally suggest that endogenous testosterone modulates neural activity during processing of negative facial emotion in healthy people, particularly males, although the exact mechanism is unknown and some conflicting results have been reported.
Steroid hormones may play a role in symptom onset, severity and the disease process associated with schizophrenia and have been linked to both cognition and negative symptoms [13] [14] [15] . However, few studies examining a possible relationship between testosterone and emotion processing in people with schizophrenia have been reported. Previous work by our lab demonstrated a strong inverse association between serum testosterone levels and activation of the bilateral middle frontal gyrus and left insula during an emotional word inhibition task in men with schizophrenia, but not in healthy men [16] , suggesting that testosterone may play a moderating role in the frontal hypoactivity observed in schizophrenia. In the second part of the present study we sought to determine the extent to which serum testosterone levels are related to neural activity in emotion processing circuitry in men with schizophrenia compared to healthy men, using a region of interest approach.
We predicted abnormal prefrontal and amygdala activity in men and women with schizophrenia during the processing of emotional faces. Given that most studies report a positive relationship between neural activity during processing of angry faces and testosterone levels in healthy men and women and abnormal neural activity during affective facial identification in schizophrenia, we predicted that the positive relationship between neural activity and circulating testosterone levels in healthy men during affective facial processing would be disrupted in men with schizophrenia.
Material and methods
2.1. Effects of emotional faces on neural activity in men and women
Participants
The study sample included 27 people with schizophrenia or schizoaffective disorder (17 male, 10 female) and 37 healthy comparison participants (20 male, 17 female). Patients were recruited from a national television documentary, the Kiloh Center at the Prince of Wales Hospital and other clinics from the South Eastern Sydney and Illawarra Area Health Service. All patients were between 21 and 51 years of age and were receiving antipsychotic medication for at least 1 year prior to taking part in the study. Clinical diagnostic interviews using the Structured Clinical Interview for DSM-IV (SCID) [17] were conducted by a trained psychologist or psychiatrist. Symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS) [18] .
Healthy comparison participants between 20 and 42 years of age were recruited from the local community via advertisements. Exclusion criteria for all participants included substance abuse or dependency within the past 5 years, seizures, central nervous system infection, uncontrolled diabetes or hypertension, a history of neurological illness, head injury with loss of consciousness and structural brain abnormalities as assessed by MRI scan. Additional exclusion factors were a concurrent DSM-IV Axis I disorder in patients and any history of DSM-IV Axis I disorder in healthy controls or their siblings.
All participants were assessed with the Wechsler Test of Adult Reading (WTAR) [19] to obtain an estimate of (premorbid) intellectual functioning in patients and a four subtest version of the Wechsler Adult Intelligence scale, 3rd edition (WAIS-III) [20] comprised of the Arithmetic, Digit Symbol, Similarities and Picture Completion subtests to assess current intellectual functioning. The study procedures were approved by the University of New South Wales and the South Eastern Sydney and Illawarra Area Health Service Ethic Committees. All participants provided written informed consent prior to participation in the study and received reimbursement for their time and expenses.
Facial stimuli and procedure
Participants were presented with 60 color pictures of human faces depicting emotional expressions (12 happy, 12 sad, 12 angry, 12 fear, 12 neutral) that alternated with a fixation cross [6] . Each face was presented for 5.5s and on presentation, participants were required to choose the emotion displayed using a button box. Given that angry facial expressions more robustly elicit differential neural activity in schizophrenia relative to controls, for the purpose of this study, we focused on neural activation for angry versus non-threat (happy and neutral) faces.
Image acquisition
Echoplanar MR brain images were acquired using a three Tesla Phillips Achieva MRI scanner with an eight channel bird-cage type head coil at Neuroscience Research Australia, Randwick, NSW, Australia. First, each participant received a T1-weighted high-resolution anatomical scan in order to screen for structural abnormalities and for co-registration (TR: 5.4 ms; TE: 2.4 ms; FOV: 256 mm; matrix: 256 × 256; sagittal plane; slice thickness: 1 mm, no gap; 180 slices). During the emotional face recognition task, 210 T2*-weighted MR images providing blood-oxygen-leveldependent (BOLD) contrast were also acquired, TR/TE = 3000/30; 21 interleaved slices, slice thickness = 3.0 mm, gap = 1.0 mm, voxel size = 3 mm × 3 mm × 3 mm; flip angle = 90 • ; field of view = 24 cm.
Demographic and task statistical analyses
Patient and control demographic factors were analysed using ttests or chi square analyses as appropriate. Percentage correct and reaction time (RT) for the emotional face recognition task were analysed using Komogorov-Smirnov two sample tests since the data were not normally distributed.
Image processing and analyses
BOLD fMRI data were preprocessed and analysed using Statistical Parametric Mapping software (SPM8; http://www.fil. ion.ucl.ac.uk/spm) running under MATLAB version 2012b. For each participant, the 210 volume functional time series were motion corrected, transformed into stereotactic space (Montreal Neurological Institute, MNI) and smoothed with a 10 mm FWHM Gaussian filter. Each dataset was then screened for excessive movement exceeding 3 mm translation on x, y or z axes, artefacts, unsuccessful normalization and for deactivation greater than three standard deviations away from the mean, which resulted in removal of one male patient and three male and two female healthy controls providing totals of 26 people with schizophrenia and 32 healthy controls for analysis.
At the first level of analysis, faces displayed with a happy or neutral affect were modelled together as "non-threat" and contrasted with angry faces for each participant. At the second level, we first constructed single sample t-test models for the healthy control and schizophrenia groups separately to assess the main task effect for the contrast of interest (angry versus non-threat). Next, a two-sample t-test applying an explicit mask including the activated frontal and limbic regions (main task effect) from the healthy control group, i.e., a functional region of interest (fROI) analysis was performed to assess activation differences between groups. These regions included as part of the fROI have also been shown to be active during the identification of emotional faces in other studies [5] [6] [7] [8] . Performance scores for angry and non-threat faces were entered as covariates of no interest as they differed significantly between the diagnostic groups (see Results). Age was entered as a covariate to account for significant differences in age between the groups. Lastly, two-sample t-tests between male and female participants, in the healthy control and schizophrenia groups separately, were performed using the fROI to assess for any sex differences in activation. False discovery rate (FDR) corrections (p<.05) were applied for both the one-sample and two-sample t tests.
Relationship between testosterone and neural activity in the inferior frontal gyrus (IFG) in men
In the second part of the study, one healthy male from the whole sample was excluded since no hormone levels were obtained from this participant. Thus, to assess the relationship between endogenous testosterone and neural activity in task-relevant areas, a subsample from the whole study, consisting of 16 males with schizophrenia (21-50 years old) and 16 healthy male controls (20-42 years old) were assessed.
Facial task, imaging acquisition and processing
The facial emotion task and stimuli, image acquisition and processing were identical to that described in the study of the whole sample above.
Hormonal assays and analyses
Samples of fasting peripheral blood were collected between 9 am and 11 am to control for diurnal variation in hormone levels. Clotted and heparinised blood were delivered on ice to the Prince of Wales Hospital South Eastern Area Laboratory Services Pathology Unit immediately following collection. Circulating serum hormone levels were obtained as measures of "total" circulating hormone levels. Testosterone, estradiol and prolactin were assayed using a chemiluminescent immunometric assay (Siemens Immulite 2000). Interassay coefficient of variation (CV) were 9.7% for testosterone and 13.5% for estradiol. Intra-and interassay coefficients of variation for prolactin were 3.4% and 6.8%, respectively. The lower sensitivity limits of assays were .7 nmol/L for testosterone, 73 pmol/L for oestrogen and 11 U/ml for prolactin. Hormone levels were compared between the groups using unmatched t-tests with alpha set at .05.
Relationship of testosterone to brain activity
We first performed correlation analyses using the region that yielded a significantly greater response in healthy controls relative to patients as our a priori fROI, which included the left IFG (maximum z: 4.13; voxels: 116; coordinates: −38, 24, 6). To assess the relationship between serum testosterone and BOLD response within the fROI, individual beta weights were extracted from the fROI using the MarsBar toolbox in SPM [21] . The beta weights were based on the mean signal of all voxels within the fROI. Partial correlation analyses between serum testosterone levels and activity in the fROI were performed separately in both groups with age as a covariate due to a significant difference in age between groups. Associations between testosterone and neural activity in the fROI of men with schizophrenia and healthy men were directly compared by performing a Fisher z-transformation applied to the Pearson's correlation coefficients.
Results

Effects of emotional faces on neural activity in men and women
Demographic and clinical characteristics of the two groups are presented in Table 1 . There were significant differences in age and current and premorbid IQ estimates between groups. There was a trend toward a significant group difference in education. There were no significant differences between groups on the basis of sex, handedness and ethnicity ratios. The people with schizophrenia in this sample were chronically ill, treated primarily with second generation antipsychotics, and displayed mild to moderate symptom severity based on PANSS scores.
Emotional face recognition task
The facial emotion identification task performance measures (Table 2 ) included reaction times (RTs) and response accuracy (% correct). The healthy control and schizophrenia groups did not differ significantly in reaction time. However, significant accuracy differences were found between the groups in relation to judging angry faces and non-threat faces, with the healthy controls performing better than the people with schizophrenia in both conditions. 
Imaging
Whole brain one-sample t-tests for the angry versus nonthreat comparison revealed similar regions of activation in both groups. The healthy control group showed increased activity in the expected regions, including frontal (inferior, medial and superior frontal gyri, insula and anterior cingulate cortex), limbic (hippocampus, amygdala, parahippocampal gyrus), parietal (left superior parietal lobule), temporal (superior temporal gyrus) and occipital (fusiform gyrus, lingual gyrus, inferior and middle occipital gyrus) regions (FDR p < .05; cluster ≥18; see Fig. 1a and Table 3 ). People with schizophrenia showed increased activity in a similar but somewhat more restricted network that included occipital (fusiform gyrus, lingual gyrus, inferior and middle occipital gyrus), temporal (fusiform gyrus) and frontal (middle and inferior frontal gyrus) regions (see Fig. 1b and Table 3 ).
In the fROI between-groups analysis of the angry versus non-threat contrast, healthy control participants demonstrated significantly greater activation than people with schizophrenia in the left inferior frontal gyrus (IFG), FDR p < .05 (see Fig. 2a ). There were no areas in which people with schizophrenia showed greater activation than controls. Using age as a covariate yielded the same region of activation but with fewer voxels (results not shown). There were no significant sex differences in activity during processing of angry versus non-threat faces in the healthy controls or the people with schizophrenia (results not shown). Table 4 presents demographic comparisons in healthy men relative to men with schizophrenia. Men with schizophrenia differed significantly from healthy men in age and current and premorbid IQ estimates (see Table 4 ). There were no significant differences between these groups in years of education, handedness and ethnicity ratios.
Relationship between testosterone and IFG neural activity in men
Hormone levels
Serum testosterone, estradiol, and prolactin levels did not differ significantly between men with schizophrenia and healthy men (see Table 4 ). 
Relationship of testosterone to brain activity
Correlation analyses between fROI activation in the IFG and circulating testosterone levels during angry versus non-threat emotional face processing conditions revealed a moderately strong, significant positive correlation (r = .63, p = .01) in men with schizophrenia but only a weak, non-significant inverse relationship in the healthy men (r = −.21, p = .45; see Fig. 2b ). Fisher's r-to-z transformation confirmed the difference between the correlations was significant, z = 2.42, p = .02, demonstrating that the relationship between testosterone and activity in the fROI was significantly greater in men with schizophrenia relative to healthy men.
Discussion
Our first hypothesis was that men and women with schizophrenia would show abnormal neural activity in frontal-limbic areas in comparison to healthy men and women. In accordance with our hypothesis and findings from previous studies, processing of angry versus non-threat facial expressions was associated with significant activation within limbic (hippocampus, amygdala, parahippocampal gyrus), occipital (fusiform gyrus, inferior and middle occipital gyri, lingual gyrus), temporal (superior temporal gyrus), parietal (left superior parietal lobule,) and frontal areas (inferior, medial and superior frontal gyri, insula) in healthy men and women, while people with schizophrenia generally showed similar regions of activity but failed to show increased activity in the limbic areas [4, 5, 8] . Between group analyses showed that healthy men and women demonstrated significantly greater activation during recognition of threat-related faces than men and women with schizophrenia in the bilateral IFG, predominantly in the left hemisphere. Other groups have shown abnormalities in the left IFG in schizophrenia during working memory, language and emotion processing tasks [8, 22] . Functional and anatomical connectivity abnormalities in the left IFG, which have been reported in schizophrenia [23] , may underlie abnormalities in neural activation observed in our schizophrenia group. Underactivation of the left IFG has also been reported during various language tasks in people with schizophrenia [24] . People with schizophrenia also had significantly lower neural activity in the left IFG when presented with emotionally ambivalent stimuli relative to healthy controls [25] . Furthermore, in processing happy faces, people with schizophrenia showed significantly decreased activation in the IFG relative to nonpsychotic siblings [26] . Our finding of significantly decreased activation in this region supports work showing that dysfunctional left IFG activity is implicated in emotion processing in people with schizophrenia. Despite growing interest in the role of sex steroids in schizophrenia, few studies have examined the relationship between testosterone and neural activity using imaging methods. To our knowledge, this is the first study to report a relationship between circulating testosterone levels and facial emotion processing in men with schizophrenia. We found a significant positive relationship between serum testosterone levels and activation of the IFG during processing of angry faces in men with schizophrenia. Although previous studies have typically reported a positive relationship between neural activity during processing of angry faces and endogenous testosterone levels in healthy men and women, we did not find a significant relationship in our healthy male sample. However, while these previous studies examined the relationship between testosterone and activity in the amygdala and orbitofrontal cortex, the present study focused on the left IFG using a fROI approach. As such, this may point to the existence of differential regional effects of endogenous testosterone. Differential explicit (as in the current study) versus implicit (as in previous studies of emotional faces) task demands between studies may also account for the differential relationships with testosterone. Taken together, these findings suggest that differences in normal serum testosterone levels may modulate emotion processing deficits in the frontal cortex of men with schizophrenia when engaged in the processing of emotional (angry) faces.
Our results indicate that having low normal testosterone levels is associated with increasingly aberrant neural processing of angry faces in men with schizophrenia. The positive correlation between testosterone and brain activation in a region where people with schizophrenia show significantly less activation relative to healthy controls suggests that higher testosterone levels within a normal range may have beneficial effects for emotion processing in men with schizophrenia. Using an emotional go/no-go paradigm integrating cognitive and emotion processing, Vercammen et al. [16] demonstrated that higher levels of testosterone were associated with better task performance and decreased activity in the prefrontal cortex, insula and precuneus in schizophrenia, suggesting that higher endogenous testosterone levels within a normal range may play an enhanced modulatory role in cognitive-emotional processing in men with schizophrenia. There was no significant difference in testosterone levels between men with schizophrenia and healthy men in our sample, suggesting that the correlation between testosterone levels and brain activation in the fROI are due to hormonal-neuronal interactions and are not based on abnormal hormone levels. However, other studies have shown a reduction of circulating testosterone levels in men with schizophrenia relative to healthy men [27] while others report no difference in circulating testosterone levels [28, 29] . Hence, evidence for circulating testosterone differences in men with schizophrenia remains controversial and it may be that only a subset of males with schizophrenia have abnormally low testosterone levels.
Testosterone has been shown to have neuroprotective effects in neurodegenerative diseases such as Alzheimer's disease and mild cognitive dysfunction [30] . Furthermore, in healthy older men, addition of exogenous testosterone has been shown to improve spatial and verbal memory [31] . One study to date has examined adjunctive treatment with testosterone in men with schizophrenia and found that those who were treated with testosterone showed significantly greater reduction of negative, but not positive symptoms [14] . Further investigation of the efficacy of testosterone as an adjunctive therapy to treat emotion processing deficits and social impairment in schizophrenia will need to be conducted.
Although we found a significant correlation between testosterone levels and brain activity in emotion processing of angry faces in schizophrenia, it remains unclear whether the modulatory effect of testosterone is a consequence of the disease process or whether changes in sex steroid signalling is part of the pathogenesis. Some studies report abnormalities in hypothalamic-pituitary-gonadal (HPA) axis function in schizophrenia that could offer possible explanations for the psychobiological role of testosterone in emotion processing deficits in schizophrenia [32] . Receptors of sex steroids are located throughout the human brain including in the cortical and subcortical areas [33] [34] [35] [36] . Testosterone effects are mediated directly through the androgen receptor or indirectly through the estrogen receptor by conversion of testosterone to estrogen. In its free form, testosterone crosses the blood-brain barrier [37] and modulates the action of neuronal cells via genomic and nongenomic mechanisms [30] . Thus, the modulatory effect of testosterone in schizophrenia could either play a role in the neurodevelopment of the disease or be a result of the disease process itself.
Limitations
It is important to point out some limitations of the present study. Prolactin-elevating antipsychotics have been shown to decrease testosterone levels, thus, the numerically increased prolactin levels in our sample may represent a potential confound. However, we did not find any statistically significant differences in serum prolactin or testosterone levels between healthy men and men with schizophrenia; thus, testosterone levels were not reduced below normal levels overall. Although the sample size of our study was consistent with other imaging studies of people with schizophrenia, future research examining the relationship between serum testosterone and brain activation in men with schizophrenia should examine larger samples and further assess potentially influencing factors (e.g. prolactin levels). For recruitment, we restricted the maximum age to 50 years as testosterone levels are known to decrease with age [38] . There was a significant difference in age between groups although there were no significant difference in testosterone levels. Importantly, when age was entered as a covariate, we obtained a similar significant although smaller region within the same ROI. Furthermore, previous studies have reported sex differences with greater activation in limbic areas (amygdala and parahippocampal gyrus) and prefrontal cortices in healthy male participants relative to healthy female participants during implicit emotional processing [39] . However, in the present study, we found no sex differences in brain activity within the healthy control group or people with schizophrenia during emotional face recognition. The absence of prominent sex differences may be due to the relatively smaller sample size when analysing males and females separately, thus, a larger sample may also be useful to examine the potential modulatory effect of sex on brain activation in people with schizophrenia. Most circulating testosterone is bound to sex hormone binding protein, which leaves only a small proportion to enter the cells and bind to receptors. Although we measured total circulating testosterone, which is an indirect measure of free testosterone, free testosterone correlates well with total testosterone and both have been used as an index of bioavailable testosterone [40] . Lastly, given the discrepant findings regarding testosterone in schizophrenia research, it is possible that the modulatory effect of testosterone in schizophrenia is present in a subgroup of the disease population. Thus, future studies with larger samples could assess differential effects on the basis of androgen and/or estrogen receptor genotype.
Conclusions
This preliminary finding provides the first evidence for a link between circulating testosterone levels and brain activity in a region characterized by hypoactivity during negative emotion face processing in men with schizophrenia, suggesting that an increase in normal levels of testosterone may have beneficial effects for emotion processing in men with schizophrenia. 
